Showing results (61-70 of 74) with videos related to
Sort By:
Pageof 8
Journal of Clinical Pharmacy and Therapeutics|May 7, 2021
Simple desensitization protocol for multiple myeloma patients with lenalidomide-induced skin rash: Case seriesTomiyuki Sugi, Mitsuo Mita, Takeo Yasu, et al.Journal of Pharmaceutical Health Care and Sciences|November 26, 2024
The risk of upper gastrointestinal bleeding associated with concomitant proton pump inhibitor administration during dual antiplatelet therapy with aspirin and prasugrel: a retrospective single-center studyYutaro Ide, Go Morikawa, Kyohei Yoshida, et al.Geriatrics (Basel, Switzerland)|March 24, 2026
Tablet Acceptability in Older Outpatients Undergoing Cancer ChemotherapyEri Hikita, Mami Oosaki, Ayano Suzuki, et al.Leukemia & Lymphoma|October 26, 2020
Lower vancomycin trough levels in adults undergoing unrelated cord blood transplantationTakeo Yasu, Takaaki Konuma, Maki Oiwa-Monna, et al.International Journal of Clinical Pharmacology and Therapeutics|November 16, 2023
Monitoring of blood levels in patients administered CYP3A4 inhibitor during the maintenance phase of venetoclax administrationToshiki Kubo, Shunsuke Matsuo, Rintaro Sogawa, et al.Annals of Hematology|September 9, 2019
Efficacy and safety of micafungin in unrelated cord blood transplant recipientsTakeo Yasu, Takaaki Konuma, Maki Oiwa-Monna, et al.Leukemia & Lymphoma|May 4, 2019
Impact of prior bortezomib therapy on the incidence of lenalidomide-induced skin rash in multiple myeloma: a propensity score-matched multi-institutional cohort studySatoshi Dote, Kaori Ito, Shoji Itakura, et al.Clinical Nephrology|October 24, 2022
Pharmacokinetics of ibrutinib in a patient with chronic lymphocytic leukemia on hemodialysisToyoji Ohtani, Akiko Tani, Yuki Namme, et al.International Journal of Molecular Sciences|March 29, 2023
SEM Observation of the Filter after Administration of Blinatumomab: A Possibility of Leakage during Home Administration Using a Portable Infusion PumpMegumi Takano, Motoki Inoue, Yuko Ikeda, et al.International Journal of Clinical Pharmacology and Therapeutics|September 21, 2018
NSAIDs may prevent EGFR-TKI-related skin rash in non-small cell lung cancer patientsYohei Iimura, Hitoshi Shimomura, Takeo Yasu, et al.Pageof 8